SG11201703729RA - Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof - Google Patents

Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof

Info

Publication number
SG11201703729RA
SG11201703729RA SG11201703729RA SG11201703729RA SG11201703729RA SG 11201703729R A SG11201703729R A SG 11201703729RA SG 11201703729R A SG11201703729R A SG 11201703729RA SG 11201703729R A SG11201703729R A SG 11201703729RA SG 11201703729R A SG11201703729R A SG 11201703729RA
Authority
SG
Singapore
Prior art keywords
tryptophan
antibodies against
kynurenine metabolites
against serotonin
serotonin
Prior art date
Application number
SG11201703729RA
Inventor
Fabiyola Selvaraj
Fred Princen
Sharat Singh
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG11201703729RA publication Critical patent/SG11201703729RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
SG11201703729RA 2014-11-19 2015-11-19 Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof SG11201703729RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462082047P 2014-11-19 2014-11-19
PCT/IB2015/058976 WO2016079708A1 (en) 2014-11-19 2015-11-19 Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof

Publications (1)

Publication Number Publication Date
SG11201703729RA true SG11201703729RA (en) 2017-06-29

Family

ID=54705246

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201703729RA SG11201703729RA (en) 2014-11-19 2015-11-19 Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof

Country Status (11)

Country Link
US (1) US20170240652A1 (en)
EP (1) EP3221353A1 (en)
JP (1) JP2018501202A (en)
KR (1) KR20170080701A (en)
CN (1) CN107257805A (en)
AU (1) AU2015348940A1 (en)
CA (1) CA2968338A1 (en)
IL (1) IL252110A0 (en)
MX (1) MX2017006537A (en)
SG (1) SG11201703729RA (en)
WO (1) WO2016079708A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190201360A1 (en) 2016-08-31 2019-07-04 Ampio Pharmaceuticals, Inc. Treatment of disease with n-acetyl kynurenine
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
CN107290517A (en) * 2017-06-28 2017-10-24 南通大学 A kind of measuring method of human hair melatonin content
US20210041460A1 (en) 2018-03-19 2021-02-11 Fujifilm Wako Pure Chemical Corporation Method for judging psychiatric disorder
KR102214571B1 (en) * 2019-08-05 2021-02-09 한국과학기술연구원 Composition or kit for diagnosing alcohol addiction and method of detecting kynurenic acid for diagnosis of alcohol addiction using the same
CN116177498B (en) * 2022-12-12 2023-11-24 江南大学 Chiral selenium nano-film with light response, preparation method thereof and application thereof in detection of L-kynurenine
CN116731165A (en) * 2023-03-23 2023-09-12 北京巴瑞医疗器械有限公司 Anti-serotonin antibody and application thereof
CN116990498A (en) * 2023-09-28 2023-11-03 山东大学齐鲁医院 Application of plasma tryptophan metabolite in diagnosis of migraine in children

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
DE69308573T2 (en) 1992-08-17 1997-08-07 Genentech Inc SPECIFIC IMMUNOADHESINE
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
WO2007075931A2 (en) * 2005-12-22 2007-07-05 Biosite Incorporated Reactive heterocyclic derivatives and methods for their synthesis and use
EP2504008A1 (en) * 2009-11-23 2012-10-03 Lexicon Pharmaceuticals, Inc. Methods and assays for the treatment of irritable bowel syndrome
RU2015155552A (en) 2013-05-24 2017-06-27 Нестек С.А. PUT-SPECIFIC METHODS FOR FORECASTING THE DIAGNOSIS OF AN IRRITED INTESTINAL SYNDROME

Also Published As

Publication number Publication date
CN107257805A (en) 2017-10-17
KR20170080701A (en) 2017-07-10
EP3221353A1 (en) 2017-09-27
CA2968338A1 (en) 2016-05-26
JP2018501202A (en) 2018-01-18
AU2015348940A1 (en) 2017-05-25
IL252110A0 (en) 2017-07-31
US20170240652A1 (en) 2017-08-24
WO2016079708A1 (en) 2016-05-26
MX2017006537A (en) 2017-08-09

Similar Documents

Publication Publication Date Title
IL304772A (en) Antibodies, uses and methods
HK1243940A1 (en) Anti-pro/latent-myostatin antibodies and uses thereof
IL252110A0 (en) Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof
EP3215147A4 (en) Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
EP3040826A4 (en) Smartphone
KR20180085054A (en) Enabling resource semantics
EP3200823A4 (en) Multivalent meditopes, meditope-binding antibodies and uses thereof
HK1232169A1 (en) Substituted 4-phenylpiperidines, their preparation and use 4-
IL252430A0 (en) Antibodies, uses and methods
EP3107569A4 (en) Anti-acth antibodies and use thereof
EP3123696A4 (en) Serving approved resources
IL252753A0 (en) Indole and azaindole derivatives, their preparation and use
IL247988A0 (en) Antibodies against hpa-1a
EP3160746A4 (en) Dye microenvironment
EP3145906A4 (en) Serotonin receptor-targeting compounds and methods
GB201405715D0 (en) Methods, apparatus and materials
IL247531A0 (en) Hexose derivatives, preparation and uses thereof
PL3386988T3 (en) Novel dihydropyranopyrimidinone derivatives, and use thereof
PL3166945T3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
EP3150576A4 (en) Substituted acetohydrazide derivatives, preparation method therefor and use
EP3297979A4 (en) Compounds and methods for modulating serotonin receptors in the periphery
EP3135167A4 (en) Detachable device, and hinge device employing same
TH1601002614A (en) containers, containers, and methods for producing containers
GB201413950D0 (en) Antibodies, uses & methods
GB201408575D0 (en) Strobe away